The overarching objectives of the Psychiatry Core are: 1) to continue to define the nature and sources of psychiatric symptoms and syndromes in Human immunodeficiency Virus (HIV) infected men and women; 2) to refine our understanding of these psychiatric phenomena by considering the life context (e.g., major life adversity; quality and quantity of social supports) in which they evolve; 3) to link psychiatric phenomena and coping behavior to evolution of neurocognitive disorders associated with HIV infection; and 4) to determine the influence of psychiatric and psychosocial variables on outcome of HIV infection (i.e., medical, social, and life quality outcomes). In addition, Psychiatry Core will provide to other cores and projects, as needed, information on psychiatric symptoms and diagnoses, social supports, and life adversity. Subjects will be 475 HIV+men and women and 125 HIV-controls, as described in the Administrative Core. Individuals with AIDS (CDC A3, B3, C1-3) will be examined every six months because of likelihood of progressive medical and neurobehavioral decline, and all other HIV-positive persons (CDC A1- 2,B1-2) and HIV-negative controls will be evaluated annually. Measures will include the Structured Clinical Interview for DSM III-R (SCID I & II), Family History Interview, Hamilton Rating Scales for Depression and Anxiety, Beck Depression Inventory, Spielberger Srate-Trait Personality and Anger Expression Scale Inventory, Psychiatric Epidemiology Research Interview, Ways of Coping Revised, and Social Support Questionnaire. A subset of individuals (N=190) will be assessed using the Composite International Diagnostic Interview, to validate this epidemiologic measure against SCID research diagnoses rendered by experienced clinicians. The availability of this unique, well characterized sample, relatively free of self-selection bias, should permit the proposed research to make an important contribution to diagnosing and understanding psychiatric symptoms and syndromes in HIV-infected men and women.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH045294-07
Application #
3737753
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Joseph, Jeymohan; Cinque, Paola; Colosi, Deborah et al. (2016) Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USA. J Virus Erad 2:243-250
Bharti, Ajay R; Woods, Steven Paul; Ellis, Ronald J et al. (2016) Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning. HIV AIDS (Auckl) 8:93-9
Weinrich, James D; Klein, Fritz; McCutchan, J Allen et al. (2014) Cluster Analysis of the Klein Sexual Orientation Grid in Clinical and Nonclinical Samples: When Bisexuality Is Not Bisexuality. J Bisex 14:349-372
Wrasidlo, Wolf; Crews, Leslie A; Tsigelny, Igor F et al. (2014) Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders. Br J Pharmacol 171:5757-73
Klein, Fritz; Weinrich, James D (2014) Homogeneous Gynephiles and Heterogeneous Androphiles: A Factor Analysis of Differences and Similarities in Attractions to the Sexes as a Function of Sexual Orientation. J Bisex 14:468-501
Fields, Jerel; Dumaop, Wilmar; Rockenstein, Edward et al. (2013) Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. J Neurovirol 19:89-101
Desplats, Paula; Dumaop, Wilmar; Smith, David et al. (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80:1415-23
Gelman, Benjamin B; Lisinicchia, Joshua G; Morgello, Susan et al. (2013) Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr 62:487-95
Soontornniyomkij, Virawudh; Everall, Ian P; Moore, David J et al. (2012) Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders. J Neurovirol 18:313-22
Soontornniyomkij, Virawudh; Moore, David J; Gouaux, Ben et al. (2012) Cerebral ?-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ?4 carriers. AIDS 26:2327-35

Showing the most recent 10 out of 98 publications